Bellicum Pharmaceuticals, Inc. BLCM
0.07 +0.07
Day range unavailable
52-week range unavailable
BLCM revenue history
Revenue is income from the company’s ordinary business activities.
1,500,000 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | 1,500,000 | -4,700,000 | -75.81% |
| FY 2021 | 2021-12-31 | 6,200,000 | 5,700,000 | 1140.00% |
| FY 2020 | 2020-12-31 | 500,000 | -6,643,000 | -93.00% |
| FY 2019 | 2019-12-31 | 7,143,000 | 6,023,000 | 537.77% |
| FY 2018 | 2018-12-31 | 1,120,000 | 935,000 | 505.41% |
| FY 2017 | 2017-12-31 | 185,000 | -203,000 | -52.32% |
| FY 2016 | 2016-12-31 | 388,000 | 106,000 | 37.59% |
| FY 2015 | 2015-12-31 | 282,000 | -1,498,000 | -84.16% |
| FY 2014 | 2014-12-31 | 1,780,000 | -161,000 | -8.29% |
| FY 2013 | 2013-12-31 | 1,941,000 | 470,670 | 32.01% |
| FY 2012 | 2012-12-31 | 1,470,330 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:02.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.